Monoclonal RhD prophylaxis: high time to evaluate efficacy

AFRICARhE consortium

doi:10.1016/S0140-6736(23)01888-3

Monoclonal RhD prophylaxis: high time to evaluate efficacy

AFRICARhE consortium

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

Original language	English
Pages (from-to)	806-807
Number of pages	2
Journal	The Lancet
Volume	403
Issue number	10429
Early online date	29 Feb 2024
DOIs	https://doi.org/10.1016/S0140-6736(23)01888-3
Publication status	Published - 8 Mar 2024

Access to Document

10.1016/S0140-6736(23)01888-3

Persistent URL (handle)

Persistent link

Cite this

@article{b9676765156f479b99278d1efbaf09b2,

title = "Monoclonal RhD prophylaxis: high time to evaluate efficacy",

author = "Verweij, {E. J.T.} and Tura, {Abera Kenay} and Tadesse Gure and Jeremia Pyuza and Bariki Mchome and Kondwani Kawaza and Peter Moons and {de Winter}, Derek and {van't Oever}, Renske and Steven Spitalnik and {van der Schoot}, {C. Ellen} and {van den Akker}, Thomas and {AFRICARhE consortium}",

year = "2024",

month = mar,

day = "8",

doi = "10.1016/S0140-6736(23)01888-3",

language = "English",

volume = "403",

pages = "806--807",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10429",

}

TY - JOUR

T1 - Monoclonal RhD prophylaxis: high time to evaluate efficacy

AU - Verweij, E. J.T.

AU - Tura, Abera Kenay

AU - Gure, Tadesse

AU - Pyuza, Jeremia

AU - Mchome, Bariki

AU - Kawaza, Kondwani

AU - Moons, Peter

AU - de Winter, Derek

AU - van't Oever, Renske

AU - Spitalnik, Steven

AU - van der Schoot, C. Ellen

AU - van den Akker, Thomas

AU - AFRICARhE consortium

PY - 2024/3/8

Y1 - 2024/3/8

UR - http://www.scopus.com/inward/record.url?scp=85186514218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186514218&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)01888-3

DO - 10.1016/S0140-6736(23)01888-3

M3 - Comment / Letter to the editor

C2 - 38431342

AN - SCOPUS:85186514218

SN - 0140-6736

VL - 403

SP - 806

EP - 807

JO - The Lancet

JF - The Lancet

IS - 10429

ER -

Monoclonal RhD prophylaxis: high time to evaluate efficacy

Access to Document

Persistent URL (handle)

Other files and links

Cite this